Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring

Aimilios Lallas, Giuseppe Argenziano, Enrico Zendri, Elvira Moscarella, Caterina Longo, Laura Grenzi, Giovanni Pellacani, Iris Zalaudek

Research output: Contribution to journalArticle

Abstract

Dermoscopy has become an integrative part of the clinical examination of skin tumors. This is because it significantly improves the early diagnosis of melanoma and non-melanoma skin cancer (NMSC) including basal cell carcinoma and keratinocyte skin cancer compared with the unaided eye. Besides its value in the noninvasive diagnosis of skin cancer, dermoscopy has also gained increased interest in the management of NMSC. Dermoscopy has been used in the preoperative evaluation of tumor margins, monitoring of the outcomes of topical treatments and post-treatment follow-up. This article provides an update on NMSC with special emphasis on dermoscopy in the diagnosis and management of basal cell carcinoma, actinic keratosis, Bowens' disease and squamous cell carcinoma.

Original languageEnglish
Pages (from-to)541-558
Number of pages18
JournalExpert Review of Anticancer Therapy
Volume13
Issue number5
DOIs
Publication statusPublished - May 2013

    Fingerprint

Keywords

  • actinic keratosis
  • basal cell carcinoma
  • Bowens' disease
  • dermoscopy
  • squamous cell carcinoma
  • treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Lallas, A., Argenziano, G., Zendri, E., Moscarella, E., Longo, C., Grenzi, L., Pellacani, G., & Zalaudek, I. (2013). Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Review of Anticancer Therapy, 13(5), 541-558. https://doi.org/10.1586/era.13.38